10 CFR 35.2063
§ 35.2063 Records of dosages of unsealed byproduct material for medical use.
United States · 10 CFR — Energy · Status: effective
Cite this
- Citation
- 10 CFR 35.2063, § 35.2063 Records of dosages of unsealed byproduct material for medical use, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/37024
- Permanent ID
ys:prov:37024@1- SHA-256
e4d0d80862603bd2344d31c77ea9fb709798032991f26df0273632a64c864075
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) A licensee shall maintain a record of dosage determinations required by § 35.63 for 3 years.
(b) The record must contain—
(1) The radiopharmaceutical;
(2) The patient's or human research subject's name, or identification number if one has been assigned;
(3) The prescribed dosage, the determined dosage, or a notation that the total activity is less than 1.1 MBq (30 µCi);
(4) The date and time of the dosage determination; and
(5) The name of the individual who determined the dosage.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.